Oncogene: An International Journal

• 

  Año 2006, Número 43

  • Clinical management of BRCA1 and BRCA2 mutation carriers

    S. M. Domchek

    págs. 5825-5831

    

  • Modifiers of risk of hereditary breast cancer

    S. A. Narod

    págs. 5832-5836

    

  • Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations

    J. Palacios, A. Osorio, Emiliano Honrado Franco

    págs. 5837-5845

    

  • Basal-like breast cancer and the BRCA1 phenotype

    N. C. Turner, J. S. Reis-Filho

    págs. 5846-5853

    

  • The role of BRCA1 in transcriptional regulation and cell cycle control

    J. E. Quinn, D. P. Harkin, P. B. Mullan

    págs. 5854-5863

    

  • The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

    K. Gudmundsdottir

    págs. 5864-5874

    

  • Fanconi anaemia genes and susceptibility to cancer

    C. G. Mathew

    págs. 5875-5884

    

  • Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects

    B. Evers, J. Jonkers

    págs. 5885-5897

    

  • Models of genetic susceptibility to breast cancer

    A. C. Antoniou

    págs. 5898-5905

    

  • ATM and breast cancer susceptibility

    N. Rahman, M. Ahmed

    págs. 5906-5911

    

  • The CHEK2 gene and inherited breast cancer susceptibility

    H. Nevanlinna

    págs. 5912-5919